|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.81 USD | +0.61% |
|
+2.78% | +11.33% |
Business description: The Carlyle Group Inc.
Number of employees: 2,300
Sales by Activity: The Carlyle Group Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Global Private Equity | 146.93Cr | 400.93Cr | 311.63Cr | 221.16Cr | 219.22Cr |
Global Market Strategies | 39Cr | 43Cr | 77Cr | 73Cr | 87Cr |
Carlyle AlpInvest | 34Cr | 41Cr | 41Cr | 34Cr | 47Cr |
Reconciling Items | 42Cr | 357.88Cr | -27Cr | -101.13Cr | 113.88Cr |
Consolidated Funds | 23Cr | 25Cr | 31Cr | 57Cr | 63Cr |
Geographical breakdown of sales: The Carlyle Group Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Americas | 178.77Cr | 543.46Cr | 256Cr | 128.9Cr | 409.64Cr |
EMEA | 62Cr | 262.93Cr | 160.38Cr | 131.89Cr | 104.76Cr |
Asia-Pacific | 52Cr | 72Cr | 27Cr | 36Cr | 28Cr |
Executive Committee: The Carlyle Group Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Harvey Schwartz
CEO | Chief Executive Officer | 62 | 15/02/2023 |
Mark Jenkins
PSD | President | 59 | - |
Jeffrey Nedelman
PSD | President | 59 | - |
Justin Plouffe
DFI | Director of Finance/CFO | 49 | - |
John Redett
DFI | Director of Finance/CFO | 58 | 01/10/2023 |
Composition of the Board of Directors: The Carlyle Group Inc.
| Director | Title | Age | Since |
|---|---|---|---|
William Conway
CHM | Chairman | 76 | 25/10/2017 |
Daniel D'Aniello
CHM | Chairman | 79 | 01/01/1987 |
David Rubenstein
CHM | Chairman | 76 | 25/10/2017 |
James Hance
BRD | Director/Board Member | 82 | 02/05/2012 |
William Shaw
BRD | Director/Board Member | 80 | 02/05/2012 |
Lawton Fitt
BRD | Director/Board Member | 72 | 02/05/2012 |
Anthony Welters
BRD | Director/Board Member | 71 | 27/10/2015 |
Derica Rice
BRD | Director/Board Member | 61 | 08/03/2021 |
Linda Filler
BRD | Director/Board Member | 66 | 01/04/2022 |
Mark Ordan
BRD | Director/Board Member | 67 | 01/04/2022 |
Holdings: The Carlyle Group Inc.
| Name | Equities | % | Valuation |
|---|---|---|---|
| 45,39,88,884 | 74.3% | 3 862 M $ | |
SENTI BIOSCIENCES, INC. 37.19% | 97,77,000 | 37.19% | 10 M $ |
SENTI BIOSCIENCES, INC. 2.12% | 2,73,045 | 2.12% | 791 831 $ |
VANTIVA 0.95% | 46,78,140 | 0.95% | 769 180 $ |
Company details: The Carlyle Group Inc.
The Carlyle Group Inc.
1001 Pennsylvania Avenue NW
20004-2505, Washington
+(202) 729-5626
http://www.carlyle.com
Group companies: The Carlyle Group Inc.
| Name | Category and Sector |
|---|---|
Abingworth Bioventures VI LP
 Abingworth Bioventures VI LP Acts as Venture Capital Fund | |
Abingworth Bioventures VI LP
Abingworth Bioventures VI LP Acts as Venture Capital Fund | |
Abingworth Bioventures VII LP
 Abingworth Bioventures VII LP Acts as Venture Capital Fund | |
Abingworth Bioventures VII LP
Abingworth Bioventures VII LP Acts as Venture Capital Fund | |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth invests in both private and public companies located across Europe and the United States. The firm targets companies operating in the fields of life sciences and healthcare sectors. It provide financing for seed, early, later and clinical co-development stage capital requirements with an investment size of USD 15 - 30 million. |
Investment Managers
|
Investment Management
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.61% | +2.78% | +30.78% | +97.33% | 2.36TCr | |
| -0.66% | -3.55% | -5.02% | +84.08% | 12TCr | |
| -0.51% | -0.45% | -4.94% | +149.62% | 12TCr | |
| -0.92% | +1.30% | -0.43% | +127.09% | 3.88TCr | |
| -0.20% | +2.76% | +22.05% | +25.55% | 1.77TCr | |
| -0.58% | -1.01% | -6.64% | +4.64% | 1.48TCr | |
| -0.08% | +4.70% | +34.10% | -14.05% | 1.34TCr | |
| -1.42% | -6.51% | +29.74% | +131.31% | 1.2TCr | |
| +0.32% | -0.57% | -30.02% | +27.57% | 1.05TCr | |
| -1.14% | -2.39% | +5.82% | +94.78% | 1.02TCr | |
| Average | -0.51% | -0.15% | +7.54% | +72.79% | 3.84TCr | |
| Weighted average by Cap. | -0.55% | -0.96% | +0.90% | +100.76% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CG Stock
- Company The Carlyle Group Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition